A Study of Nivolumab or Nivolumab Plus Experimental Medication BMS-986205 With or Without Bacillus Calumette-Guerin (BCG) in BCG Unresponsive Bladder Cancer That Has Not Invaded Into the Muscle Wall of the Bladder
Public ClinicalTrials.gov record NCT03519256. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Open-label Study of Nivolumab or Nivolumab/BMS-986205 Alone or Combined With Intravesical BCG in Participants With BCG-Unresponsive, High-Risk, Non-Muscle Invasive Bladder Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A study to evaluate the safety and tolerability of nivolumab or nivolumab Plus BMS-986205 with or without BCG in BCG-Unresponsive non-muscle invasive Bladder Cancer.
Study identification
- NCT ID
- NCT03519256
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 142 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2, 2018 (Actual)
- Primary completion
- Aug 22, 2022 (Actual)
- Completion
- Aug 24, 2022 (Actual)
- Last update posted
- Jun 1, 2023
2018 – 2022
United States locations
- U.S. sites
- 25
- U.S. states
- 17
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution - 0044 | Los Angeles | California | 90033 | — |
| Local Institution - 0081 | Riverside | California | 92505 | — |
| Local Institution - 0087 | San Francisco | California | 94158 | — |
| Local Institution - 0125 | Tampa | Florida | 33612 | — |
| Local Institution - 0056 | Hapeville | Georgia | 30354 | — |
| Local Institution - 0023 | New Lenox | Illinois | 60451 | — |
| Wichita Urology Group | Wichita | Kansas | 67226 | — |
| Local Institution - 0001 | Baltimore | Maryland | 21287 | — |
| Local Institution - 0077 | Ann Arbor | Michigan | 48109 | — |
| Local Institution - 0032 | Minneapolis | Minnesota | 55455 | — |
| Local Institution - 0040 | Omaha | Nebraska | 68114 | — |
| Local Institution - 0144 | New Brunswick | New Jersey | 08903 | — |
| Deleware Valley Urology, LLC | Voorhees Township | New Jersey | 08043 | — |
| Local Institution - 0051 | New York | New York | 10016 | — |
| Local Institution - 0058 | Columbus | Ohio | 43212 | — |
| Local Institution - 0036 | Bala-Cynwyd | Pennsylvania | 19004 | — |
| Local Institution - 0049 | Charleston | South Carolina | 29425 | — |
| Local Institution - 0002 | Myrtle Beach | South Carolina | 29572 | — |
| Local Institution - 0057 | Chattanooga | Tennessee | 37403 | — |
| Urology Clinics Of North Texas, Pa | Dallas | Texas | 75231 | — |
| Local Institution - 0048 | Houston | Texas | 77030 | — |
| Local Institution - 0140 | Houston | Texas | 77030 | — |
| Local Institution - 0047 | Lubbock | Texas | 79415 | — |
| Urology San Antonio Research, Pa | San Antonio | Texas | 78229 | — |
| Local Institution - 0141 | Seattle | Washington | 98195 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 63 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03519256, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 1, 2023 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03519256 live on ClinicalTrials.gov.